Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Neoplasms × durvalumab × Clear all

Phase

Phase 2 32 Phase 1 11 Phase 3 7 Phase 1/2 7 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unresectable Non-small Cell Lung Cancer (NSCLC) 1 Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Propofol 5 Sevoflurane 3 Saline Solution 3 Erlotinib Hydrochloride 3 Carboplatin 3 Acetaminophen 3 Nivolumab 2 Midazolam 2 Lidocaine 2 Docetaxel 2 Cryotherapy 2 Bupivacaine 2 Bronchoscopy 2 Anesthesia, Inhalation 2 trametinib 1 sotorasib 1 pegfilgrastim 1 icotinib 1 endostar protein 1 durvalumab 1 dabrafenib 1 capmatinib 1 camrelizumab 1 beta Carotene 1 atezolizumab 1 Zoledronic Acid 1 Vitamin A 1 Tobacco Use Cessation Devices 1 Sunitinib 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04613284 2020-11-03

RELIEF

Shanghai Chest Hospital

Phase 4 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡